Unsupervised principal component analysis with the main EMT-enriched genes (FUCA1, SGCB, IL15, WIPF1, TGFB1, ECM2, ADM12, POSTN, PRRX1, VIM, BASP1, and EMP3) allowed for the discrimination of the subgroup of BMAL1-dependent CRC patients (p = 3.23 × 10−5, Figure 1C). This evidence concerns the gene BASP1 and colorectal carcinoma.